{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:34:43Z","timestamp":1795008883225,"version":"4.9.1"},"reference-count":59,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is mixed evidence on the association between headache and attention-deficit\/hyperactivity disorder (ADHD), as well as headache and ADHD medications. This systematic review and meta-analysis investigated the co-occurrence of headache in children with ADHD, and the effects of ADHD medications on headache. Embase, Medline and PsycInfo were searched for population-based and clinical studies comparing the prevalence of headache in ADHD and controls through January 26, 2021. In addition, we updated the search of a previous systematic review and network meta-analysis of double-blind randomized controlled trials (RCTs) on ADHD medications on June 16, 2020. Trials of amphetamines, atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil with a placebo arm and reporting data on headache as an adverse event, were included. Thirteen epidemiological studies and 58 clinical trials were eligible for inclusion. In epidemiological studies, a significant association between headache and ADHD was found [odds ratio (OR) = 2.01, 95% confidence interval (CI) = 1.63\u20132.46], which remained significant when limited to studies reporting ORs adjusted for possible confounders. The pooled prevalence of headaches in children with ADHD was 26.6%. In RCTs, three ADHD medications were associated with increased headache during treatment periods, compared to placebo: atomoxetine (OR = 1.29, 95% CI = 1.06\u20131.56), guanfacine (OR = 1.43, 95% CI = 1.12\u20131.82), and methylphenidate (OR = 1.33, 95% CI = 1.09\u20131.63). The summarized evidence suggests that headache is common in children with ADHD, both as part of the clinical presentation as such and as a side effect of some standard medications. Monitoring and clinical management strategies of headache in ADHD, in general, and during pharmacological treatment are recommended.<\/jats:p>","DOI":"10.1017\/s0033291721004141","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T11:34:14Z","timestamp":1634038454000},"page":"14-25","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":28,"title":["Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis"],"prefix":"10.1017","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0826-4847","authenticated-orcid":false,"given":"Pei-Yin","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabriye Selin","family":"\u015eahpazo\u011flu \u00c7akmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"H\u00e4ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalmar","family":"Nobel Norrman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan K.","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Banaschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Coghill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"B\u00f6lte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"S0033291721004141_ref48","first-page":"Cd009885","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"Storeb\u00f8","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"S0033291721004141_ref2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2010.01.2112"},{"key":"S0033291721004141_ref7","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2008.09.1907"},{"key":"S0033291721004141_ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-54"},{"key":"S0033291721004141_ref51","volume-title":"RStudio: Integrated Development for R","author":"RStudio","year":"2015"},{"key":"S0033291721004141_ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1087054719865779"},{"key":"S0033291721004141_ref10","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S73167"},{"key":"S0033291721004141_ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12036"},{"key":"S0033291721004141_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30269-4"},{"key":"S0033291721004141_ref54","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03"},{"key":"S0033291721004141_ref26","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"S0033291721004141_ref46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008"},{"key":"S0033291721004141_ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2016.09.034"},{"key":"S0033291721004141_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-006-0047-6"},{"key":"S0033291721004141_ref41","first-page":"Cd009996","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents","volume":"2","author":"Punja","year":"2016","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"S0033291721004141_ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-017-1045-4"},{"key":"S0033291721004141_ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0883073808327831"},{"key":"S0033291721004141_ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-016-0929-z"},{"key":"S0033291721004141_ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-016-0675-0"},{"key":"S0033291721004141_ref49","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1024"},{"key":"S0033291721004141_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01531.x"},{"key":"S0033291721004141_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412454226"},{"key":"S0033291721004141_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e318193060e"},{"key":"S0033291721004141_ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0840-x"},{"key":"S0033291721004141_ref58","unstructured":"Wells, G. A. , Shea, B. , O'Connell, D. , Peterson, J. , Welch, V. , Losos, M. , & Tugwell, P. (2009) The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Retrieved from http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"S0033291721004141_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.06.003"},{"key":"S0033291721004141_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2014.08.001"},{"key":"S0033291721004141_ref27","doi-asserted-by":"publisher","DOI":"10.1177\/0883073816653782"},{"key":"S0033291721004141_ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700"},{"key":"S0033291721004141_ref32","first-page":"1","volume-title":"Headache and comorbidities in childhood and adolescence","author":"Lateef","year":"2017"},{"key":"S0033291721004141_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2011.10.008"},{"key":"S0033291721004141_ref47","first-page":"l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research ed.)"},{"key":"S0033291721004141_ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-79"},{"key":"S0033291721004141_ref59","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-311803"},{"key":"S0033291721004141_ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.12.1157"},{"key":"S0033291721004141_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2018.06.001"},{"key":"S0033291721004141_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.02.003"},{"key":"S0033291721004141_ref52","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-3482"},{"key":"S0033291721004141_ref34","doi-asserted-by":"publisher","DOI":"10.1111\/head.13639"},{"key":"S0033291721004141_ref55","doi-asserted-by":"publisher","DOI":"10.1177\/0883073815601498"},{"key":"S0033291721004141_ref3","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2013.841544"},{"key":"S0033291721004141_ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2006.01072.x"},{"key":"S0033291721004141_ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.1999.1901032.x"},{"key":"S0033291721004141_ref6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318271f812"},{"key":"S0033291721004141_ref19","first-page":"77","article-title":"Comorbidities of sleep disorders in childhood and adolescence: Focus on migraine","volume":"5","author":"Dosi","year":"2013","journal-title":"Nature and Science of Sleep"},{"key":"S0033291721004141_ref56","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.6.904"},{"key":"S0033291721004141_ref36","first-page":"138","article-title":"The inverse of the Freeman \u2013 Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"The American Statistician"},{"key":"S0033291721004141_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-010-0140-6"},{"key":"S0033291721004141_ref15","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1389894"},{"key":"S0033291721004141_ref50","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.206.151"},{"key":"S0033291721004141_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-198712000-00001"},{"key":"S0033291721004141_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.12.028"},{"key":"S0033291721004141_ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03793.x"},{"key":"S0033291721004141_ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-57"},{"key":"S0033291721004141_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyt261"},{"key":"S0033291721004141_ref53","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000157"},{"key":"S0033291721004141_ref8","volume-title":"Attention-Deficit hyperactivity disorder third edition: A clinical workbook","author":"Barkley","year":"2005"},{"key":"S0033291721004141_ref37","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-282X2011000200010"},{"key":"S0033291721004141_ref21","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177729756"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291721004141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T09:07:22Z","timestamp":1640336842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291721004141\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0033291721004141"],"URL":"https:\/\/doi.org\/10.1017\/s0033291721004141","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2021. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}